Mölnlycke Health Care
| Aktiebolag | |
| Industry | Medical devices |
| Founded | 1849, Mölnlycke |
| Headquarters | Gothenburg, Sweden |
|
Key people
|
Richard Twomey, CEO |
| Revenue | € 856 million (2009) |
| Owner | Investor AB (96%) |
|
Number of employees
|
7,400+ |
| Website | www.molnlycke.com |
Mölnlycke Health Care is a Swedish medical device company headquartered in Gothenburg and active internationally. The company manufactures and sells wound care and single-use surgical products and is a service provider to the healthcare sector. The surgical division includes medical devices such as drapes, gowns, facemasks, and headwear. The wound care division includes medical device wound healing solutions such as dressings, compression products and skin care products and emollients. Featured products in wound care include those with Safetac® technology available exclusively on Mepitel® , Mepilex® , and other dressings. The wound care product assortment also includes WoundEL® electrostimulation for hard-to-heal wounds, wound dressings such as Mepore® , compression bandages, dermatology products and retention products such as Tubifast®.
The company was founded in 1849 by Gustaf Ferdinand Hennig in Mölnlycke as a textile manufacturer. In the 1940s Mölnlycke began supplying the health care industry with products, such as gauze.
1975 Mölnlycke AB was acquired by Svenska Cellulosa Aktiebolaget (SCA) (publ) where it made up their Clinical division. At that time SCA was known as Bowater-Scott, and the new company, called Sancella Pty Limited, manufactured personal care products.
1997 SCA sold the Clinical products division to Nordic Capital who merged it with Kolmi-Set acquired by Tamro and named it Mölnlycke Health Care AB. Mölnlycke Health Care started operations as an independent company in 1998.
2001, Mölnlycke Health Care acquired the single-use surgical BARRIER product line from Johnson & Johnson.
2005 Mölnlycke Health Care AB was acquired from Nordic Capital by Apax Partners in June 2005 and subsequently merged with Medlock Medical and Regent Medical. The merged company became Mölnlycke Health Care Group.
2007 Apax Partners sold Mölnlycke Health Care Group to Investor AB and Morgan Stanley in January 2007.
...
Wikipedia